Blog

Future Trials: Hormone+ Consent, Fewer Knee Visits, Telehealth & QoL

Analytical predictions for clinical trials: patient-centered consent for hormone-positive breast cancer, fewer in-person knee visits, telehealth onboarding for healthy volunteers, and robust QoL/caregiver metrics in MCI—plus timeline optimization and regulatory context.

Guide to Align Cross-Border IND/CTA, Sandbox Edits & Regulatory Paths

Practical Q&A on aligning cross-border IND/CTA efforts, sandbox edits for adaptive protocols, data integrity in decentralized MCI/flu trials, and regulatory routes for regenerative dentistry and tissue-engineering therapies.

ClinConnect Expert: MCI Risk, Breast PI Alignment & Cervical Funnels

Practical insights on risk-based monitoring for MCI, sponsor-investigator alignment in breast cancer, an activation playbook for knee OA sites, and adaptive recruitment funnels for cervical screening—plus a clear patient prep guide.

ClinConnect: 4 Actionable Tips for Diversity, Caregivers & Consent

{ "content": "ClinConnect: 4 Actionable Tips for Diversity, Caregivers & Consent\n\nClinical trials in 2024–2025 show measurable shifts: decentralized methods rose, enrollment diversity crept upward where outreach was targeted, and caregiver-reported outcomes began to appear in more protocols. ...

What if trials prioritized consent, sensory, caregiver & PRO needs?

Practical steps to make trials participant-centered: co-design consent, create sensory-friendly tinnitus BCI visits, embed caregiver workflows for breast cancer survivorship, and integrate PROs for MCI/PPA. Regulatory guidance supports this shift.

Case Study: Caregiver-Centered Consent Improves Breast Cancer Trials

Data-driven case study shows caregiver-centered consent, paired with remote symptom diaries and flexible visit models, boosts retention and improves breast cancer trial survivorship experience across diverse regulatory contexts.

How to: PPA Consent, MCI Caregivers, CLBP Monitoring & Flu-Season BC

Practical, step-by-step tactics to improve consent for PPA, integrate caregivers in MCI trials, run low-burden CLBP monitoring, and coordinate flu-season enrollment for breast cancer patients—ready-to-use steps and FAQs for immediate implementation.